What is MagnaWave?
MagnaWave operates at the intersection of advanced medical technology and veterinary wellness, specializing in Pulsed Electromagnetic Field (PEMF) therapy. By providing non-invasive solutions designed to restore biological balance, the company serves a broad spectrum of clients, ranging from high-performance equine athletes to domestic pets and livestock. The organization distinguishes itself through a robust ecosystem that includes accredited certification programs, comprehensive 24/7 support, and a commitment to long-term product reliability via 10-year warranties. This integrated approach has allowed MagnaWave to cultivate a global network of certified practitioners, effectively positioning the brand as a leader in the non-pharmacological therapeutic space.
How much funding has MagnaWave raised?
MagnaWave has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in MagnaWave
PPP
Public-Private Partnership
What's next for MagnaWave?
With this latest infusion of capital, MagnaWave is poised to accelerate its ambitious goal of impacting 10 million lives by 2035. The strategic roadmap likely involves expanding its practitioner network into untapped international markets and enhancing its R&D capabilities to refine PEMF delivery systems. As the company transitions through this late-stage growth phase, the focus will shift toward operational efficiency and the deepening of its digital support infrastructure. By leveraging its established reputation for quality and training, MagnaWave is set to solidify its market dominance, ensuring that its therapeutic solutions remain the gold standard for both professional and personal animal care applications.
See full MagnaWave company page
